Noxopharm Says Holder of Existing Convertible Notes Green Light Maturity Date Extension, Shares Fall 5%

MT Newswires Live

Sep 23, 2025

Noxopharm (ASX:NOX) said that the holders of its existing convertible notes, with a total aggregate note face value of AU$2.6 million, approved the extension of the maturity date of their convertible notes to Jan. 2, 2027, according to a Tuesday Australian bourse filing.

The noteholders will be paid accrued interest of AU$327,000 in aggregate on the convertible notes in cash for the period ending Jan. 2, 2026, with the interest accruing from Jan. 2, 2026, capitalized daily until maturity.

The extension will allow the company to access rebate funds of around AU$2.8 million from the Australian Federal Government's Research and Development Tax Incentive Scheme for the financial year ended June 30.

It entered into an unsecured loan agreement with 4F Investments, which is owned and controlled by Noxopharm Chairman Fred Bart, for a AU$1.25 million unsecured loan to Noxopharm. Interest will be payable at 12% per annum on the loan capitalized daily until maturity.

The firm's shares fell 5% in recent trading on Tuesday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2569765446"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2569765446\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2569765446?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-23 12:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2569765446","market":"hk","top_or_hot":-1,"title":"Noxopharm Says Holder of Existing Convertible Notes Green Light Maturity Date Extension, Shares Fall 5%","media":"MT Newswires Live","content":"<html><body><p> Noxopharm (ASX:NOX) said that the holders of its existing convertible notes, with a total aggregate note face value of AU$2.6 million, approved the extension of the maturity date of their convertible notes to Jan. 2, 2027, according to a Tuesday Australian bourse filing.</p><p>The noteholders will be paid accrued interest of AU$327,000 in aggregate on the convertible notes in cash for the period ending Jan. 2, 2026, with the interest accruing from Jan. 2, 2026, capitalized daily until maturity.</p><p>The extension will allow the company to access rebate funds of around AU$2.8 million from the Australian Federal Government's Research and Development Tax Incentive Scheme for the financial year ended June 30.</p><p>It entered into an unsecured loan agreement with 4F Investments, which is owned and controlled by Noxopharm Chairman Fred Bart, for a AU$1.25 million unsecured loan to Noxopharm. Interest will be payable at 12% per annum on the loan capitalized daily until maturity.</p><p>The firm's shares fell 5% in recent trading on Tuesday.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Noxopharm Says Holder of Existing Convertible Notes Green Light Maturity Date Extension, Shares Fall 5%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNoxopharm Says Holder of Existing Convertible Notes Green Light Maturity Date Extension, Shares Fall 5%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-09-23 12:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Noxopharm (ASX:NOX) said that the holders of its existing convertible notes, with a total aggregate note face value of AU$2.6 million, approved the extension of the maturity date of their convertible notes to Jan. 2, 2027, according to a Tuesday Australian bourse filing.</p><p>The noteholders will be paid accrued interest of AU$327,000 in aggregate on the convertible notes in cash for the period ending Jan. 2, 2026, with the interest accruing from Jan. 2, 2026, capitalized daily until maturity.</p><p>The extension will allow the company to access rebate funds of around AU$2.8 million from the Australian Federal Government's Research and Development Tax Incentive Scheme for the financial year ended June 30.</p><p>It entered into an unsecured loan agreement with 4F Investments, which is owned and controlled by Noxopharm Chairman Fred Bart, for a AU$1.25 million unsecured loan to Noxopharm. Interest will be payable at 12% per annum on the loan capitalized daily until maturity.</p><p>The firm's shares fell 5% in recent trading on Tuesday.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7508","symbol_name":"医药生物股","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2569765446","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2569765446","pubTimestamp":1758601237,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Noxopharm  said that the holders of its existing convertible notes, with a total aggregate note face value of AU$2.6 million, approved the extension of the maturity date of their convertible notes to Jan. 2, 2027, according to a Tuesday Australian bourse filing.The noteholders will be paid accrued interest of AU$327,000 in aggregate on the convertible notes in cash for the period ending Jan. 2, 2026, with the interest accruing from Jan. 2, 2026, capitalized daily until maturity.The extension will allow the company to access rebate funds of around AU$2.8 million from the Australian Federal Government's Research and Development Tax Incentive Scheme for the financial year ended June 30.It entered into an unsecured loan agreement with 4F Investments, which is owned and controlled by Noxopharm Chairman Fred Bart, for a AU$1.25 million unsecured loan to Noxopharm. Interest will be payable at 12% per annum on the loan capitalized daily until maturity.The firm's shares fell 5% in recent tradin","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7508":"医药生物股","BK7501":"新冠治疗股","NOX.AU":"NOXOPHARM LTD","XAO.AU":"标普/澳交所 普通股指数","XJO.AU":"标普/澳交所 200指数","BK7067":"生物科技","XKO.AU":"标普/澳交所 300指数"},"translate_title":"Noxopharm表示现有可转换票据持有人批准延长到期日，股价下跌5%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XKO.AU":0.68,"XAO.AU":0.68,"NOX.AU":1,"XJO.AU":0.68},"content_text":"Noxopharm (ASX:NOX) said that the holders of its existing convertible notes, with a total aggregate note face value of AU$2.6 million, approved the extension of the maturity date of their convertible notes to Jan. 2, 2027, according to a Tuesday Australian bourse filing.The noteholders will be paid accrued interest of AU$327,000 in aggregate on the convertible notes in cash for the period ending Jan. 2, 2026, with the interest accruing from Jan. 2, 2026, capitalized daily until maturity.The extension will allow the company to access rebate funds of around AU$2.8 million from the Australian Federal Government's Research and Development Tax Incentive Scheme for the financial year ended June 30.It entered into an unsecured loan agreement with 4F Investments, which is owned and controlled by Noxopharm Chairman Fred Bart, for a AU$1.25 million unsecured loan to Noxopharm. Interest will be payable at 12% per annum on the loan capitalized daily until maturity.The firm's shares fell 5% in recent trading on Tuesday.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}